EY recently published their 18th annual Pulse of the MedTech Industry report, highlighting | This week on "The Top Line," ...

“These promising data add to the evidence supporting GSK’s RSV vaccine and could help expand protection to more adults at ...

After making a splash in the U.K. earlier this year, GSK is laying out plans for its biggest U.S. manufacturing investment ...

The CDC seems to be taking an “if it ain’t broke” approach to its annual flu vaccine push. | The CDC seems to be taking an ...

The recent trial flop for Ztalmy, this time in tuberous sclerosis complex (TSC)-associated seizures, leaves the company in a ...

Many people don’t know they’re eligible. | Moderna has identified a fundamental barrier to vaccination: many people don’t ...

Rentschler acquired the Milford facility—its entry into the U.S. market—from Shire in 2019. The CDMO also operates a third ...

With an expanded recommendation from the Center for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization ...

The groups behind the letter alleged that Novo Nordisk’s plant purchases could hinder not only the Danish drugmaker’s chief ...

There’s no denying it: the radiopharmaceuticals boom is here to stay. | Telix on Tuesday unveiled the spin-off of Rhine ...

The war is on between compounding pharmacies making knockoff versions of popular weight loss drugs and pharma giants Novo ...

Pfizer has told 75 employees in Sanford, North Carolina, that their positions have been eliminated. | Pfizer has told 75 ...